Case Study

The Largest Parkinson's Disease Study Ever Attempted Is Being Made Possible Only With Mobile Research Nurses

Source: PCM Trials
nurse comforting patient


Because Parkinson's disease is a progressive brain disorder that leads to shaking and stiffness, eventually causing difficulty with walking, balance, and coordination, patients are at very high risk of fractures from multiple and sometimes severe falls that can lead to permanent disability and even death. Researchers are studying whether zoledronic acid, approved by the FDA to treat osteoporosis by increasing bone strength, will reduce fractures in people with Parkinson’s disease.

The Trial of Parkinson’s and Zoledronic acid (TOPAZ)1 is seeking to enroll 3,500 participants over the age of 60, making it the largest double-blind, placebo-controlled, randomized clinical trial ever attempted in people with parkinsonism.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader